According to iX Biopharma latest financial reports the company has an operating margin of -1.61%, an decrease of -4377.50% to 2022. At the end of 2022 company had an operating margin of 0.04%.
Year | Operating Margin | Change |
---|---|---|
2023 | -1.61% | -4377.50% |
2022 | 0.04% | -100.58% |
2021 | -6.48% | -44.20% |
2020 | -11.61% | - |